Complications and survival after total pelvic exenteration

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Cathrine Kure Pleth Nielsen, Aarhus Universitet
  • ,
  • Mette Møller Sørensen, Aarhus Universitet
  • ,
  • Henrik Kidmose Christensen, Aarhus Universitet
  • ,
  • Jonas Amstrup Funder

Background: Pelvic exenteration is a procedure with high morbidity despite careful patient selection. This study investigates potential associations between perioperative markers and major postoperative complications including survival. Methods: Retrospectively collected data for 195 consecutive patients who underwent total pelvic exenteration (January 2015–February 2020) at a single tertiary university hospital were analyzed. Results: The 30-day mortality was 0.5%, and the rate of major postoperative complications (≥3 Clavien-Dindo) was 34.5%. Low albumin level (p = 0.02) and blood transfusion (p = 0.02) were significantly correlated with a major postoperative complication in univariate analyses. This had no impact on survival. Positive margins (p = 0.003), liver metastasis (p = 0.001) were related to poor survival in multivariate analyses for colorectal patients. A Charlson Comorbidity Index >6 (p < 0.05) was associated with poor survival in all patients. Conclusion: The occurrence of major postoperative complication does not negatively impact the overall survival. Pelvic exenteration is a potential life-prolonging operation when negative margins can be obtained, despite known risks for complications. Comorbidity is a predictor for inferior outcomes.

OriginalsprogEngelsk
TidsskriftEuropean Journal of Surgical Oncology
Vol/bind48
Nummer6
Sider (fra-til)1362-1367
Antal sider6
ISSN0748-7983
DOI
StatusUdgivet - jun. 2022

Se relationer på Aarhus Universitet Citationsformater

ID: 286180391